Company / Current Assets per Share
Gilead Sciences Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$14.72
FY2025
5-year range
$11.52 / $15.39
FY2021-FY2025
Trend
-4.3%
vs FY2024
Sector context
#46 of 210
Health Care
What the data says
Gilead Sciences's current assets per share of $14.72 is higher than 78% of companies in the Health Care sector (FY2025). Current Assets per Share has fluctuated over the past 10 years, ranging from $11.52 in FY2022 to $27.40 in FY2018.
Based on SEC 10-K filings.
14.72 in FY2025 with a 5-year CAGR of +3.1%. Top quartile in the Health Care sector.
Improved from $12.90 to $14.72 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
-91.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 4.3% year-over-year.
- Ranks #46 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.72 | -4.3% |
| FY2024 | $15.39 | +19.3% |
| FY2023 | $12.90 | +12.0% |
| FY2022 | $11.52 | -2.2% |
| FY2021 | $11.78 | -6.8% |
| FY2020 | $12.64 | -46.5% |
| FY2019 | $23.63 | -13.7% |
| FY2018 | $27.40 | +12.8% |
| FY2017 | $24.29 | +69.0% |
| FY2016 | $14.38 | -13.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026